Thus, given the shared involvement of iNOS in mediating NFκB-mediated HPS and muscle wasting, any therapy that targets the iNOS-NO pathway may prove to be an effective therapeutic strategy in both diseased states2, 6, 11. Here, NOS2 is linked to Hermansky-Pudlak syndrome.